|

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

RECRUITINGSponsored by Gérond'if
Actively Recruiting
SponsorGérond'if
Started2024-07-01
Est. completion2027-07-02
Eligibility
Age80 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06427304

Summary

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography

Eligibility

Age: 80 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged ≥ 80 years
* Hospitalised for decompensation of heart failure in the last 12 months
* Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
* Subjects able to undergo a bone scintigraphy scan
* Subjects willing to participate

Exclusion Criteria:

* Subjects refusing to participate
* Subjects admitted to palliative care unit.
* Subjects under guardianship
* Subjects with a definite diagnosis of cardiac amyloidosis

Conditions2

Cardiac AmyloidosisHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.